FDA approval of exenatide, its first generic injectable GLP-1 agonist, Amneal (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva Pharmaceuticals (2025) Exenatide, DailyMed (2025) Byetta, DailyMed (2025) Liraglutide (generic Victoza), DailyMed (2025) Liraglutide (generic Saxenda), DailyMed (2025) Victoza, DailyMed (2025) Saxenda, DailyMed (2025) Compounding and the FDA: Questions and answers, U.S
Moderate use of carbonated beverages
Skin Brightening and Luminosity Glutathione inhibits the tyrosinase enzyme the rate-limiting step in melanin synthesis causing a systemic shift from eumelanin (brown-black pigment) to phaeomelanin (red-yellow pigment)
CV risk : MACE reduction with appropriate agents
Adding another layer of complexity, a multinational survey revealed that only 26% of clinicians viewed obesity as a chronic disease, and fewer than half routinely recorded it as such in patients medical files (Dixon et al., 2025)